RCSI research shows new benefits of weight loss for type 2 diabetes

18 January 2024: Researchers in the School of Population Health at RCSI University of Medicine and Health Sciences have provided new evidence of the health benefits of weight loss efforts that lead to diabetes remission for type 2 diabetes patients.  

For participants in the weight-loss trial who were able to achieve remission i.e. reduce the need for medications and reduce their HbA1c levels (a measure of blood sugar control), the research found there was a 40% lower rate of cardiovascular disease and 33% lower rate of chronic kidney disease in this group. 

While previous trials have shown that substantial weight loss using diet and lifestyle can reverse type 2 diabetes, the new research published in Diabetologia is among the first to show that reversal of diabetes, in turn, affects cardiovascular and kidney disease outcomes. The research was led by Professor Edward Gregg, Head of the RCSI School of Population Health. 

The study called Look AHEAD (Action for Health in Diabetes) monitored over 5,000 patients during a period of 12 years. The magnitude of risk reduction was greatest for participants with evidence of at least four years of remission. 

“Using lessons learned from this study we can help inform diabetes treatment methods and improve quality of life for people with type 2 diabetes. It has highlighted the significance of weight loss for achieving remission from type 2 diabetes and then long-term positive cardiovascular and kidney disease outcomes” said Professor Gregg. 

Over the course of the study, the effect intensive lifestyle intervention was compared with that of diabetes support and education on cardiovascular disease and other long-term health conditions. It was noted that although 18% of participants achieved remission at some point during follow-up, the percentage of participants with current remission had decreased to 3% by the 8th year of the study, underlining the challenges of keeping weight off using lifestyle interventions.  

RCSI researchers collaborated on the study with colleagues Wake Forest University, Brown University and other study sites in the United States.

ENDS 

For further information:  

Laura Anderson, Communications Officer, RCSI 

087 199 0399/ lauraanderson@rcsi.ie  

About RCSI University of Medicine and Health Sciences 

RCSI University of Medicine and Health Sciences is ranked first in the world for its contribution to UN Sustainable Development Goal 3, Good Health and Well-being, in the Times Higher Education (THE) University Impact Rankings 2023. 

Exclusively focused on education and research to drive improvements in human health worldwide, RCSI is an international not-for-profit university, headquartered in Dublin. It is among the top 300 universities worldwide in the World University Rankings (2024). RCSI has been awarded Athena Swan Bronze accreditation for positive gender practice in higher education.  

Founded in 1784 as the Royal College of Surgeons in Ireland (RCSI) with national responsibility for training surgeons in Ireland, today RCSI is an innovative, world-leading international health sciences university and research institution offering education and training at undergraduate, postgraduate and professional level. 

Visit the RCSI MyHealth Expert Directory to find the details of our experts across a range of healthcare issues and concerns. Recognising their responsibility to share their knowledge and discoveries to empower people with information that leads them to better health, these clinicians and researchers are willing to engage with the media in their area of expertise.